| Mrs Magan L Shipp, CNP | |
|
107 Eureka St, Batesville, MS 38606-2533 | |
| (662) 563-7681 | |
| (662) 563-2611 |
| Full Name | Mrs Magan L Shipp |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 107 Eureka St, Batesville, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285016279 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R883141 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Panola Medical Center | Batesville, MS | Hospital |
| Baptist Memorial Hospital North Ms | Oxford, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Batesville Clinic, P.a. | 0840265690 | 5 |
News Archive
Employers nationwide are recognizing that the federal government intends to expand and strengthen Occupational Safety and Health Administration (OSHA) authority, and ensure strict adherence to industry-specific guidelines. National claims and risk management service provider Avizent is preparing for these changes by expanding its in-house Loss Control program to serve clients nationwide.
Researchers have lifted fertility rates in older female mice with small doses of a metabolic compound that reverses the aging process in eggs, offering hope for some women struggling to conceive.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. In the United States alone, there are more than 250,000 people living with SCI; approximately three million worldwide are affected.
A test to diagnose two very serious diseases such as ALS and FTD when the pathologies have not yet appeared, thereby providing doctors and patients with essential information tools to tackle them early and develop new treatments.
› Verified 8 days ago
| Entity Name | Batesville Clinic, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164604682 PECOS PAC ID: 0840265690 Enrollment ID: O20040826000705 |
News Archive
Employers nationwide are recognizing that the federal government intends to expand and strengthen Occupational Safety and Health Administration (OSHA) authority, and ensure strict adherence to industry-specific guidelines. National claims and risk management service provider Avizent is preparing for these changes by expanding its in-house Loss Control program to serve clients nationwide.
Researchers have lifted fertility rates in older female mice with small doses of a metabolic compound that reverses the aging process in eggs, offering hope for some women struggling to conceive.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. In the United States alone, there are more than 250,000 people living with SCI; approximately three million worldwide are affected.
A test to diagnose two very serious diseases such as ALS and FTD when the pathologies have not yet appeared, thereby providing doctors and patients with essential information tools to tackle them early and develop new treatments.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Magan L Shipp, CNP 107 Eureka St, Batesville, MS 38606-2533 Ph: (662) 563-7681 | Mrs Magan L Shipp, CNP 107 Eureka St, Batesville, MS 38606-2533 Ph: (662) 563-7681 |
News Archive
Employers nationwide are recognizing that the federal government intends to expand and strengthen Occupational Safety and Health Administration (OSHA) authority, and ensure strict adherence to industry-specific guidelines. National claims and risk management service provider Avizent is preparing for these changes by expanding its in-house Loss Control program to serve clients nationwide.
Researchers have lifted fertility rates in older female mice with small doses of a metabolic compound that reverses the aging process in eggs, offering hope for some women struggling to conceive.
Arena Pharmaceuticals, Inc. and Eisai Inc. reported today that top-line results from the one-year lorcaserin BLOOM-DM trial demonstrate statistically significant weight loss in obese and overweight patients with type 2 diabetes. In this trial, lorcaserin met all three co-primary efficacy endpoints. In addition, as described below, lorcaserin patients taking lorcaserin 10 mg twice daily (BID) achieved statistically significant improvements in multiple secondary endpoints, including HbA1c, as compared to patients randomized to placebo.
Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. In the United States alone, there are more than 250,000 people living with SCI; approximately three million worldwide are affected.
A test to diagnose two very serious diseases such as ALS and FTD when the pathologies have not yet appeared, thereby providing doctors and patients with essential information tools to tackle them early and develop new treatments.
› Verified 8 days ago
Aarrin Marie Mcdougal, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 568 Highway 6 E, Batesville, MS 38606 Phone: 662-655-0206 | |
Mrs. Christiana Britt, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 107 Eureka St, Batesville, MS 38606 Phone: 662-563-7681 Fax: 662-563-2611 | |
Pamela Calvert, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 318 Turkey Trak, Batesville, MS 38606 Phone: 662-444-0045 | |
Olivia Babb Cooper, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 171 Lakewood Dr, Batesville, MS 38606 Phone: 662-655-0311 | |
Lauren Durham, CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 555 Highway 6 E, Batesville, MS 38606 Phone: 662-578-2030 Fax: 662-578-2050 | |
Shonve Ball, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 154 Woodland Rd, Batesville, MS 38606 Phone: 731-394-1145 | |
Genessa Nicole Egerson, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 303 Medical Center Dr, Batesville, MS 38606 Phone: 662-563-5611 |